Clinical Validation of a Blood Loss Monitoring System
Condition(s) studied
Study summary
This observational study aims to evaluate the practicality of a novel multifunctional intraoperative blood loss monitoring system in real-world surgical settings. The primary questions it seeks to address are:
Using the direct measurement method as the reference standard, what is the magnitude of measurement error of the monitoring system, and does it tend to overestimate or underestimate blood loss? Does the monitoring system demonstrate superior accuracy compared with visual estimation, the gravimetric method, and the hemoglobin concentration-based method? During surgery, intraoperative blood loss will be measured simultaneously using five approaches: the novel multifunctional monitoring system, the direct measurement method, visual estimation, the gravimetric method, and the hemoglobin concentration method. These measurements will be conducted without interfering with the surgical procedure.
Eligibility
Primary outcome measure(s)
- Absolute error of the automatic intraoperative blood loss monitor compared with the direct measurement method — At the end of surgery
Absolute error is defined as the numerical difference between intraoperative blood loss measured by the automatic intraoperative blood loss monitor and intraoperative blood loss measured by the direct measurement method. A positive value indicates that the monitor overestimates blood loss compared with the direct measurement method, whereas a negative value indicates underestimation. Unit of Measure: Milliliters (mL)
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| Gansu Provincial People's Hospital | Lanzhou | Gansu | |
| Lanzhou University Frist Hospital | Lanzhou | Gansu | |
| Lanzhou University Second Hospital | Lanzhou | Gansu |
More Lanzhou University Second Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07617428 on ClinicalTrials.gov ↗ ← All trials in China